SyntheMed, Inc. (SYMD.OB) Receives FDA Approval for REPEL-CV® Adhesion Barrier for Use in Pediatric Cardiac Surgery
SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products. SyntheMed reached a major milestone…